References |
1 |
Aniline-based inhibitors of influenza H1N1 virus acting on hemagglutinin-mediated fusion. J Med Chem. 2018 Jan 11;61(1):98-118.
|
2 |
Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes. J Biol Inorg Chem. 2007 Mar;12(3):313-23.
|
3 |
The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities. Trends Biotechnol. 2007 Jul;25(7):289-98.
|
4 |
Cytochromes P450: a structure-based summary of biotransformations using representative substrates Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742.
|
5 |
Aniline and its metabolites generate free radicals in yeast
|
6 |
Human metabolism and excretion kinetics of aniline after a single oral dose
|
7 |
Aniline derivative-induced methemoglobin in rats
|